KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Debt Ratio (2016 - 2025)

Emergent BioSolutions (EBS) has 16 years of Debt Ratio data on record, last reported at 0.43 in Q4 2025.

  • For Q4 2025, Debt Ratio fell 9.15% year-over-year to 0.43; the TTM value through Dec 2025 reached 0.43, down 9.15%, while the annual FY2025 figure was 0.43, 9.15% down from the prior year.
  • Debt Ratio reached 0.43 in Q4 2025 per EBS's latest filing, down from 0.45 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.48 in Q4 2024 and bottomed at 0.14 in Q4 2022.
  • Average Debt Ratio over 5 years is 0.32, with a median of 0.29 recorded in 2021.
  • Peak YoY movement for Debt Ratio: tumbled 48.24% in 2022, then skyrocketed 95.01% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.27 in 2021, then crashed by 48.24% to 0.14 in 2022, then soared by 72.89% to 0.24 in 2023, then surged by 95.01% to 0.48 in 2024, then fell by 9.15% to 0.43 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.43 in Q4 2025, 0.45 in Q3 2025, and 0.47 in Q2 2025.